BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38804889)

  • 1. Prior COVID-19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case-control study.
    Semnani K; Sohrabi M; Alavijeh PE; SeyedAlinaghi S; Esmaeili S; Halabchi F; Alizadeh Z; Salami A; Khaneshan AS
    Immun Inflamm Dis; 2024 May; 12(5):e1275. PubMed ID: 38804889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undiagnosed Pulmonary Tuberculosis (TB) and Coronavirus Disease 2019 (COVID-19) in Adults Dying at Home in a High-TB-Burden Setting, Before and During Pandemic COVID-19: An Autopsy Study.
    Sabet N; Omar T; Milovanovic M; Magajane T; Mosala M; Moloantoa T; Kato-Kalule N; Semedo LV; Swanepoel F; Wallis C; Abraham P; Lebina L; Variava E; Martinson N
    Clin Infect Dis; 2023 Aug; 77(3):453-459. PubMed ID: 37041678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection and pulmonary tuberculosis in children and adolescents: a case-control study.
    Swanepoel J; van der Zalm MM; Preiser W; van Zyl G; Whittaker E; Hesseling AC; Moore DAJ; Seddon JA
    BMC Infect Dis; 2023 Jun; 23(1):442. PubMed ID: 37386354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proportion of tuberculosis cases in Tanzania attributable to human immunodeficiency virus.
    van Cleeff MR; Chum HJ
    Int J Epidemiol; 1995 Jun; 24(3):637-42. PubMed ID: 7672908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First case series and literature review of coronavirus disease 2019 (COVID-19) associated pulmonary tuberculosis in Southeast Asia: Challenges and opportunities.
    Siranart N; Sowalertrat W; Sukonpatip M; Suwanpimolkul G; Torvorapanit P
    J Infect Public Health; 2023 Jan; 16(1):80-89. PubMed ID: 36495816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of COVID-19 for delaying the diagnosis and treatment of pulmonary tuberculosis-Tianjin, China.
    Zhang G; Yu Y; Zhang W; Shang J; Chen S; Pang X; Oeltmann JE; Moonan PK; Chen M; Zhang F
    Front Public Health; 2022; 10():937844. PubMed ID: 36530737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for tuberculosis: A case-control study in Addis Ababa, Ethiopia.
    Shimeles E; Enquselassie F; Aseffa A; Tilahun M; Mekonen A; Wondimagegn G; Hailu T
    PLoS One; 2019; 14(4):e0214235. PubMed ID: 30939169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of airborne infection isolation in potential cases of pulmonary tuberculosis.
    England JH; Byrne DW; Harris BD; Talbot TR
    Infect Control Hosp Epidemiol; 2020 May; 41(5):505-509. PubMed ID: 32172696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact on tuberculosis diagnostic during COVID-19 pandemic in a tertiary care hospital.
    Ruiz-Bastián M; Díaz-Pollán B; Falces-Romero I; Toro-Rueda C; García-Rodríguez J;
    Enferm Infecc Microbiol Clin (Engl Ed); 2024 Mar; 42(3):135-139. PubMed ID: 36737366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of risk factors for development of active pulmonary tuberculosis in northern part of Ethiopia: a matched case control study.
    Berhe G; Enquselassie F; Aseffa A
    Ethiop Med J; 2013 Oct; 51(4):227-37. PubMed ID: 24696973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study.
    Min J; Ko Y; Kim HW; Koo HK; Oh JY; Jeong YJ; Kang HH; Park KJ; Hwang YI; Kim JW; Ahn JH; Jegal Y; Kang JY; Lee SS; Park JS; Kim JS
    J Korean Med Sci; 2022 Jan; 37(3):e20. PubMed ID: 35040295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of tuberculosis/COVID-19 co-infection and factors associated with SARS-CoV-2 infection in pulmonary tuberculosis patients at a respiratory diseases center: a cross-sectional study.
    Mangamba LE; Sike CIM; Tochie JN; Dalle GN; Nkouagmi N; Balkissou AD; Bille BE; Ngahane BHM; Moukoko CEE
    Pan Afr Med J; 2023; 44():204. PubMed ID: 37484595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa.
    Loveday M; Cox H; Evans D; Furin J; Ndjeka N; Osman M; Naidoo For The National Tb Think Tank 'Optimising Tb Treatment Outcomes' Task Team K
    S Afr Med J; 2020 Nov; 110(12):1160-1167. PubMed ID: 33403958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of tuberculosis among COVID-19 suspected cases in Ghana.
    Afum T; Asare P; Asante-Poku A; Darko-Otchere I; Morgan PA; Bedeley E; Asandem DA; Musah AB; Siam IM; Tetteh P; Adusi-Poku Y; Frimpong-Manso R; Bonney JHK; Ampofo W; Yeboah-Manu D
    PLoS One; 2021; 16(12):e0261849. PubMed ID: 34962960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis Coinfection among COVID-19 Patients: Clinical Presentation and Mortality in a Tertiary Lung Hospital in Indonesia.
    Muflihah H; Yulianto FA; Rina ; Sampurno E; Ferdiana A; Rahimah SB
    Int J Mycobacteriol; 2024 Jan; 13(1):58-64. PubMed ID: 38771281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of type 2 diabetes with pulmonary tuberculosis patients,2013-2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic.
    Wang Z; Zhao S; Zhang A; Quan B; Duan C; Liang M; Yang J
    Tuberculosis (Edinb); 2024 May; 146():102499. PubMed ID: 38442538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.